AMGN(Amgen Inc.) 的财务报表:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $25.98B | $26.32B | $28.19B | $33.42B | $36.75B |
| 毛利润 | $19.52B | $19.92B | $19.74B | $20.57B | $24.71B |
| 营业利润 | $7.64B | $9.57B | $7.90B | $7.26B | $9.08B |
| 净利润 | $5.89B | $6.55B | $6.72B | $4.09B | $7.71B |
| 经营现金流 | $9.26B | $9.72B | $8.47B | $11.49B | $9.96B |
| 自由现金流 | $8.38B | $8.79B | $7.36B | $10.39B | $8.10B |
| 摊薄每股收益 | $10.28 | $12.11 | $12.49 | $7.56 | $14.23 |